Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (321-330 of 415) with videos related to

Pageof 42
Sort By:
Lancet (London, England)|July 6, 2004
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trialChristian Laurent, Charles Kouanfack, Sinata Koulla-Shiro, et al.
The Journal of Infectious Diseases|May 24, 2023
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort StudyJohannes M Schwenke, Christian W Thorball, Isabella C Schoepf, et al.
British Journal of Clinical Pharmacology|March 25, 2021
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trialPerrine Courlet, Charlotte Barbieux, Delphine Sculier, et al.
Pharmacogenetics and Genomics|November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsRubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Wellcome Open Research|November 30, 2023
MOSAIC: A cohort study of human mpox virus diseaseElise Pesonel, Isabelle Hoffmann, Laetitia Guiraud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in SwitzerlandMarius Zeeb, Burcu Tepekule, Katharina Kusejko, et al.
The Journal of Infectious Diseases|November 26, 2022
Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering ApproachMarco Labarile, Tom Loosli, Marius Zeeb, et al.
The Journal of Infectious Diseases|March 6, 2019
A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic DiseasesKatharina Kusejko, Nadine Bachmann, Sandra E Chaudron, et al.
HIV Medicine|October 15, 2025
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025Juan Ambrosioni, Laura I Levi, Jasmini Alagaratnam, et al.
Nature Communications|February 23, 2021
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxisFrédérique Hovaguimian, Huldrych F Günthard, Christoph Hauser, et al.
Pageof 42

Showing results (321-330 of 415) with videos related to

Sort By:
Pageof 42
Lancet (London, England)|July 6, 2004
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trialChristian Laurent, Charles Kouanfack, Sinata Koulla-Shiro, et al.
The Journal of Infectious Diseases|May 24, 2023
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort StudyJohannes M Schwenke, Christian W Thorball, Isabella C Schoepf, et al.
British Journal of Clinical Pharmacology|March 25, 2021
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trialPerrine Courlet, Charlotte Barbieux, Delphine Sculier, et al.
Pharmacogenetics and Genomics|November 1, 2012
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsRubin Lubomirov, Mona Arab-Alameddine, Margalida Rotger, et al.
Wellcome Open Research|November 30, 2023
MOSAIC: A cohort study of human mpox virus diseaseElise Pesonel, Isabelle Hoffmann, Laetitia Guiraud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in SwitzerlandMarius Zeeb, Burcu Tepekule, Katharina Kusejko, et al.
The Journal of Infectious Diseases|November 26, 2022
Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering ApproachMarco Labarile, Tom Loosli, Marius Zeeb, et al.
The Journal of Infectious Diseases|March 6, 2019
A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic DiseasesKatharina Kusejko, Nadine Bachmann, Sandra E Chaudron, et al.
HIV Medicine|October 15, 2025
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025Juan Ambrosioni, Laura I Levi, Jasmini Alagaratnam, et al.
Nature Communications|February 23, 2021
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxisFrédérique Hovaguimian, Huldrych F Günthard, Christoph Hauser, et al.
Pageof 42